FDA Inspection
Biomat USA, Inc.Biomat USA, Inc. – FDA Inspection, Feb 11, 2011
Record Details
This FDA Inspection record concerns Biomat USA, Inc., with an inspection on February 11, 2011, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Biomat USA, Inc.
- Inspection Date
- February 11, 2011
- Product Type
- Biologics
View Company Profile
ID · 36b3d83b-8577-4193-8e3c-e8c0ca63829b
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 709291
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Biomat USA, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| October 28, 2024 | Not classified | Dallas District Office | |
| October 30, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 21, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 28, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Biomat USA, Inc.
- FDA Inspection 1252027 - 2024-10-28
- FDA Inspection 1071794 - 2018-10-30
- FDA Inspection 975112 - 2016-06-21
- FDA Inspection 868133 - 2014-02-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.